Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug;28(8):1004-1008.
doi: 10.1016/j.jsps.2020.06.022. Epub 2020 Jul 3.

COVID-19: Clinical aspects and therapeutics responses

Suliman Khan  1   2 , Ashaq Ali  3   4 , Hongwei Shi  5 , Rabeea Siddique  1   2 , Shabana  3   4 , Ghulam Nabi  6 , Junjie Hu  7 , Tiejun Wang  8 , Men Dong  3   4 , Wajid Zaman  9 , Guang Han  10
Affiliations

COVID-19: Clinical aspects and therapeutics responses

Suliman Khan et al. Saudi Pharm J. 2020 Aug.

Abstract

COVID-19 has created havoc in the world by causing thousands of demises in a short period of time. Up till now, several attempts have been made for potential therapeutics against SARS-COV2. In this retrospective, single-center study, we extracted data from 122 COVID-19, RT-PCR confirmed patients. who were treated with a new treatment strategy of lianhuaqingwen with Arbidol Hydrochloride. The patients were either asymptomatic or had mild symptoms for COVID-19 disease. Of 122 patients 21 (17.21%) patients developed severe conditions of COVID-19, while total 111 (90.9%) experienced mild symptoms such as fever in 93 (76.22%) patients, cough in 23 (20.17%) and muscle pain were observed in total 8 (7%) patients. Furthermore our newly applied drugs combination (Lianhuaqingwen and Arbidol Hydrochloride) showed therapeutic effects in 5-7 days in patients with mild symptoms with 98% recovery rate. These results indicate that COVID-19 patients with mild symptoms can be treated with Lianhuaqingwen and Arbidol Hydrochloride. However, extensive clinical investigations are required to confirm the effectiveness of these drugs.

Keywords: COVID-19; Mild symptoms; Recoveries; TCM; Therapeutics.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Ratio of Sign and Symptoms of in 122, COVID-19 Patients.
See this image and copyright information in PMC

References

    1. Ashraf, M.A., Shokouhi, N., Shirali, E., Davari-tanha, F., Memar, O., Kamalipour, A., Azarnoush, A., Mabadi, A., Ossareh, A., Sanginabadi, M., Mokhtari Azad, T., Aghaghazvini, L., Ghaderkhani, S., Poordast, T., Pourdast, A., Nazemi, P., 2020. COVID-19 in Iran, a comprehensive investigation from exposure to treatment outcomes. MedRxiv, 2020.04.20.20072421. https://doi.org/10.1101/2020.04.20.20072421.
    1. Chen N., Zhou M., Dong X., Qu J., Gong F., Han Y., Qiu Y., Wang J., Liu Y., Wei Y., Xia J., Yu T., Zhang X., Zhang L. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet. 2020;395(10223):507–513. doi: 10.1016/S0140-6736(20)30211-7. - DOI - PMC - PubMed
    1. Conti P, Y. A., 2020. Coronavirus COV-19/SARS-CoV-2 affects women less than men: clinical response to viral infection. J. Biol. Regul. Homeost Agents. https://www.ncbi.nlm.nih.gov/pubmed/32253888 - PubMed
    1. Dong L., Xia J.W., Gong Y., Chen Z., Yang H.H., Zhang J., He J., Chen X.D. Effect of lianhuaqingwen capsules on airway inflammation in patients with acute exacerbation of chronic obstructive pulmonary disease. Evid.-Based Complement. Alternat. Med. 2014;2014 doi: 10.1155/2014/637969. - DOI - PMC - PubMed
    1. Duan Z.-P., Jia Z.-H., Zhang J., Liu S., Chen Y., Liang L.-C., Zhang C.-Q., Zhang Z., Sun Y., Zhang S.-Q., Wang Y.-Y., Wu Y.-L. Natural herbal medicine Lianhuaqingwen capsule anti-influenza A (H1N1) trial: a randomized, double blind, positive controlled clinical trial. Chin. Med. J. 2011;124(18):2925–2933. http://europepmc.org/abstract/MED/22040504 - PubMed